Terrance P. Coyne - Aug 9, 2023 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role: EVP & CFO
Signature: /s/ Sean Weisberg, as Attorney-in-Fact for Terrance P. Coyne
Stock symbol: RPRX
Transactions as of: Aug 9, 2023
Transactions value $: -$2,305,028
Form type: 4
Date filed: 8/11/2023, 05:00 PM
Previous filing: Aug 8, 2023
Next filing: Aug 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPRX	Class A Ordinary Shares	Sale	-$1.15M	-37.5K	-4.34%	$30.72	828K	Aug 9, 2023	By TPC RP 2021, LLC	F1
transaction	RPRX	Class A Ordinary Shares	Sale	-$1.15M	-37.5K	-4.53%	$30.75	790K	Aug 10, 2023	By TPC RP 2021, LLC	F2
holding	RPRX	Class A Ordinary Shares						1.5K	Aug 9, 2023	Direct
holding	RPRX	Class A Ordinary Shares						1.45K	Aug 9, 2023	By Spouse
holding	RPRX	Class A Ordinary Shares						23.3K	Aug 9, 2023	By IRA
holding	RPRX	Class A Ordinary Shares						24.2K	Aug 9, 2023	By Spouse's IRA

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.49 to $31.41 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.55 to $31.07 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.49 to $31.41 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.55 to $31.07 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

In addition to the holdings of Class A Ordinary Shares disclosed above, the Reporting Person and family vehicles controlled by the Reporting Person hold limited partnership interests in RPI US Partners 2019, LP and ICAI Interests that are exchangeable into 5,595,681 Class A Ordinary Shares.